Twist & Shout & Sell It All Out
After a crazy week of earnings, we had a light day today. With that said, one company’s results had investors “twisting and shouting” their way out the door.
The mid-cap biotech company posted $54.2 million in revenue, beating the $54.1 million estimates. Driving those results were 134,000 gene shipments to 2,060 customers, up from 1,800 customers in the prior year. Its loss per share of $0.74 was also better than the $1.13 expected. 👍